United Therapeutics EVP sells 8,300 shares
United Therapeutics executive vice president and general counsel Paul A. Mahon exercised stock options and sold the resulting shares in a planned transaction.
Rhea-AI Filing Summary
United Therapeutics executive vice president and general counsel Paul A. Mahon exercised stock options and sold the resulting shares in a planned transaction. On May 7, 2026, he exercised options for 8,300 shares of common stock at a strike price of $146.03 per share and carried out open‑market sales totaling 8,300 shares.
The sales were executed in multiple trades at prices including about $597.54, $596.19, $588.51 and several weighted‑average prices in the mid‑$580s, according to footnotes. The filing states these transactions were made under a pre‑arranged Rule 10b5‑1 trading plan, indicating they were scheduled in advance rather than timed discretionarily.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 8,300 shares ($3.66M approx. pre-tax spread)
Exercise and Sale
10 txns
Insider
MAHON PAUL A
Role
EVP & GENERAL COUNSEL
Sold
8,300 shs ($4.87M)
Approx. gross sale proceeds
$4.87M
Approx. exercise cost
$1.21M
Approx. pre-tax spread
$3.66M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 8,300 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,300 | $146.03 | $1.21M |
| Sale | Common Stock | 80 | $582.8575 | $47K |
| Sale | Common Stock | 1,475 | $584.0698 | $862K |
| Sale | Common Stock | 994 | $585.1779 | $582K |
| Sale | Common Stock | 1,689 | $586.1724 | $990K |
| Sale | Common Stock | 2,970 | $587.6086 | $1.75M |
| Sale | Common Stock | 820 | $588.5084 | $483K |
| Sale | Common Stock | 70 | $596.19 | $42K |
| Sale | Common Stock | 202 | $597.54 | $121K |
Holdings After Transaction:
Stock Option — 300 contracts (Direct);
Common Stock — 45,172 shares (Direct)
Footnotes (7)
- F1. This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $582.42 to $583.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $583.72 to $584.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $584.83 to $585.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $585.86 to $586.695. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $587.185 to $588.105. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $588.195 to $588.7025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 8,300 shares
Option shares exercised: 8,300 shares
Option strike price: $146.03 per share
+4 more
7 metrics
Shares sold
8,300 shares
Open-market sales of common stock on May 7, 2026
Option shares exercised
8,300 shares
Stock options converted into common stock on May 7, 2026
Option strike price
$146.03 per share
Exercise price for stock options converted into common shares
Sale block price
$597.54 per share
One reported open-market sale of 202 shares
Sale block price
$596.19 per share
One reported open-market sale of 70 shares
Largest sale block
2,970 shares
Single largest trade of common stock on May 7, 2026
Remaining options
300 options
Stock options remaining after the 8,300-share exercise
Key Terms
Rule 10b5-1 plan, stock options, weighted average price, open-market sale, +1 more
5 terms
Rule 10b5-1 plan financial
"exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
stock options financial
"This is an exercise of stock options and sale of the resulting shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UTHR executive Paul Mahon report?
Paul A. Mahon reported an exercise-and-sell transaction involving stock options. He exercised options for 8,300 shares of United Therapeutics common stock and sold all 8,300 resulting shares in multiple open-market trades on May 7, 2026 under a pre-arranged plan.
Did Paul Mahon’s UTHR transactions involve stock options?
Yes. Mahon exercised stock options covering 8,300 shares of United Therapeutics common stock at a strike price of $146.03 per share. A corresponding derivative entry shows these options converting into common shares, which were then sold in the same-day open-market transactions.
Does Paul Mahon still hold United Therapeutics stock options after this filing?
Yes, the derivative transaction table shows 300 stock options remaining after the exercise of 8,300 options. The exercised options originally had an exercise date of March 15, 2020 and an expiration date of March 15, 2027, with a conversion rate of one option to one common share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
